Your browser doesn't support javascript.
loading
Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells.
Berrien-Elliott, Melissa M; Yuan, Jinyun; Swier, Lauryn E; Jackson, Stephanie R; Chen, Collin L; Donlin, Maureen J; Teague, Ryan M.
Afiliação
  • Berrien-Elliott MM; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri.
  • Yuan J; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri.
  • Swier LE; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri.
  • Jackson SR; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri.
  • Chen CL; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri.
  • Donlin MJ; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri. Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri.
  • Teague RM; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri. Saint Louis University Cancer Center, St. Louis, Missouri. rteague@slu.edu.
Cancer Immunol Res ; 3(2): 116-24, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25516478
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Proteínas com Domínio T / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Proteínas com Domínio T / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article